Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC
Spigel, D Senan, S Langer, C Raben, D Perez, B Ozguroglu, M Daniel, D Villegas, A Vicente, D
Spigel, D
Senan, S
Langer, C
Raben, D
Perez, B
Ozguroglu, M
Daniel, D
Villegas, A
Vicente, D
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Faivre-Finn C, Spigel DR, Senan S, Langer CJ, Raben D, Perez B, et al. 1363O Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. Ann Oncol. 2018;29(suppl_8):488.